Zilixir Biotech

About:

Zilixir Biotech is an AI-based synthetic biotech firm developing a platform for protein structure prediction, design, and related services.

Website: https://www.zelixir.com/

Top Investors: Huimei Capital, Q Ventures, Hongfeng Investment Management, Life Capital, Qingdao Qingchi Venture Capital

Description:

Zilixir Biotech develops a new protein design technology that offers possibilities for human exploration of the complex life sciences. SWORD™ protein design technology integrates binding pockets, new drug skeleton design, activity prediction, ADME/T prediction, etc., and has had some achievements in these areas, fully demonstrating the effectiveness of protein design.

Total Funding Amount:

100M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2021-04-21

Contact Email:

contact(AT)zelixir.com

Founders:

Number of Employees:

Last Funding Date:

2023-05-25

IPO Status:

Private

© 2024 MyAiNote.com